Mergers and Acquisitions

Small-Molecule Contract Services Update

August 01, 2018

This article provides a sampling of the latest investments, expansions, and acquisitions by small-molecule contract service providers.

Waters Acquires Mass Spec Technology

July 27, 2018

Pharmaceutical Technology's In the Lab eNewsletter

Waters’ acquisition of Prosolia’s DESI technology boosts its mass spectrometry imaging portfolio.

Sangamo Therapeutics to Acquire TxCell

July 26, 2018

The acquisition would combine Sangamo’s ex vivo gene-editing capabilities with TxCell's regulatory T-cell (Treg) expertise to create chimeric antigen receptor (CAR)-Treg therapies.

Cambrex to Acquire Halo Pharma for $425 Million

July 23, 2018

The acquisition will place Cambrex into the finished dosage form CDMO market.

Otsuka to Acquire Visterra for $430 Million

July 16, 2018

Otsuka Pharmaceutical will acquire Visterra, a clinical-stage biotechnology company focused on developing antibody-based therapies, for approximately $430 million.

Takeda Receives US Clearance for $62-Billion Acquisition of Shire

July 11, 2018

The company has received clearance from the United States Federal Trade Commission for the proposed acquisition of Shire, a deal valued at $62 billion.

Amazon to Acquire Online Pharmacy

July 02, 2018

Amazon will acquire PillPack, an online pharmacy that offers pre-sorted doses of medications and home delivery.

Sanofi to Sell European Generics Business for $2.2 Billion

June 29, 2018

Sanofi will sell Zentiva, its European generics business, to private equity investor Advent International.

Sanofi Completes $4.8-Billion Ablynx Acquisition

June 20, 2018

The acquisition is expected to strengthen Sanofi’s R&D strategy with Ablynx’s nanobody technology platform.

Roche to Acquire Foundation Medicine for $2.4 Billion

June 20, 2018

The acquisition is expected to strengthen Roche’s personalized healthcare strategy.